Combination therapy for the prevention and treatment of osteoporosis
US6043026A · kind A · utility
11Cited by
8References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 1998 |
| Grant date | Mar 28, 2000 |
| Priority date | — |
| Expiry date | May 1, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/6425
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The combination of an estrogen receptor modulator and a growth hormone secretagogue is useful in the treatment or prevention of diseases involving bone resorption, especially osteoporosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.